IO NewsWire

October 14, 2010 07:30 ET

(OTCBB: APDN) Proprietary Product Opening Possibilities in Luxury Goods Market

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire.

NEW YORK, NY--(Marketwire - October 14, 2010) -  Applied DNA Sciences (OTCBB: APDN) announced yesterday the figures relating to their 5 year agreement with an exclusive European luxury brand.

Applied DNA will be marking the products with a unique botanical DNA to authenticate the product and link them to a specific user. This will be extremely helpful in combating the counterfeiting of luxury brands.

As the luxury goods market is estimated to exceed $220 billion (2009 estimate by Bain & Co) in 2010, the counterfeiting of products is estimated at $24 billion annually (US Dept of Commerce). The need to ensure the validity of all products is more important than ever.

Applied DNA Sciences' unique and proprietary products can ensure that even the highest quality of "knock-off" merchandise is not mistaken for an authentic item, and those responsible are easier to prosecute.

For more information, please visit

Other active stocks are Luxottica Group (NYSE: LUX) Tiffany & Co (NYSE: TIF) United States Oil & Gas (PINKSHEETS: USOG)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information